Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015, Sandu Pharmaceuticals has informed that it enclosed summary of proceedings of the 37th Annual General Meeting held on Friday, 30th September 2022.
The above information is a part of company’s filings submitted to BSE.